Streetbeat News

Price Targets

SAIA

Raymond James analyst Patrick Tyler Brown maintains an Outperform rating on Saia (NASDAQ:SAIA) but lowers the price target from $450 to $420.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 12:24 pm

ORI

Raymond James analyst C. Gregory Peters maintains an Outperform rating on Old Republic Intl (NYSE:ORI) and raises the price target from $29 to $30.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 12:18 pm

STEL

Raymond James analyst David Feaster has maintained an Outperform rating on Stellar Bancorp (NYSE:STEL) but lowered the price target from $27 to $24.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 12:08 pm

NOV

Raymond James analyst James Rollyson has maintained an Outperform rating on NOV (NYSE:NOV) and raised the price target from $28 to $29.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 12:05 pm

MBIN

Raymond James analyst Daniel Tamayo has maintained a Strong Buy rating on Merchants Bancorp (NASDAQ:MBIN) and raised the price target from $41 to $44.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 11:50 am

HTBK

Raymond James analyst David Feaster maintains an Outperform rating on Heritage Commerce (NASDAQ:HTBK), but lowers the price target from $10.5 to $9.5.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 11:48 am

FRME

Raymond James analyst Daniel Tamayo has maintained an 'Outperform' rating on First Merchants (NASDAQ:FRME), but lowered the price target from $36 to $33.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 11:35 am

VMAR

Ascendiant Capital analyst Lucas Ward has initiated coverage on Vision Marine (NASDAQ:VMAR) with a Buy rating and a price target of $4.5.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 10:59 am

NAMS

RBC Capital analyst Leonid Timashev has initiated coverage on NewAmsterdam Pharma (NASDAQ:NAMS) with an Outperform rating and a price target of $25.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 10:53 am

BCPC

HC Wainwright & Co. analyst Raghuram Selvaraju maintains a 'Buy' rating on Balchem (NASDAQ:BCPC) but lowers the price target from $165 to $135.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 10:53 am